Bi-directional metabolic reprogramming between cancer cells and T cells reshapes the anti-tumor immune response.

Journal:
PLOS Biology
Published:
DOI:
10.1371/journal.pbio.3003284
Affiliations:
3
Authors:
6
Go to article
Institutions Authors Share
National Key Laboratory of Immunity and Inflammation, China
2.500000
 0.42
Suzhou Institute of Systems Medicine (ISM), CAMS & PUMC, China
2.500000
 0.42
Suzhou Municipal Hospital, China
1.000000
 0.17
Interested in Oncology and Carcinogenesis?